Abstract
The authors suggest that functional testing for activated protein C resistance is cheaper and more clinically relevant than genetic testing to detect a factor V Leiden mutation in identifying persons who are at risk for thromboembolism.
MeSH terms
-
Activated Protein C Resistance / diagnosis*
-
Activated Protein C Resistance / genetics
-
Factor V / genetics*
-
Female
-
Genotype
-
Humans
-
Partial Thromboplastin Time / economics
-
Phenotype
-
Point Mutation
-
Polymerase Chain Reaction / economics
Supplementary concepts
-
Thrombophilia due to Activated Protein C Resistance